Skip to main content
. 2015 Dec 24;2(4):ofv155. doi: 10.1093/ofid/ofv155

Figure 6.

Figure 6.

The effects of human cytomegalovirus (HCMV) and endothelin receptor type B (ETBR) blocker, BQ788, on endothelial cells proliferation, migration, vasculogenecity, and leukocyte recruitment. (A) Cell proliferation assay by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) was performed in human umbilical vein cells (HUVECs) uninfected or HCMV-infected, untreated or treated with BQ788 at the indicated time points after infection. Optical density was read at 590 nm with reference wavelength at 670 nm. (B) Light microscopic images (×4) of the wound healing assay were taken at different times after the “scratch” of HUVEC monolayers uninfected or HCMV-infected treated with BQ788. (C) Light microscopic images (×4) of tube formation by HUVEC uninfected or HCMV-infected and treated with BQ788. (D) Light microscopic images of flow adhesion assay in cells stimulated with tumor necrosis factor-α (TNFα) and uninfected or HCMV-infected (left panel). The number of adherent cells was quantified for all the conditions (right panel). Values are mean ± standard deviation; P < .05 was considered to be statistically significant; *P = .01–.05; **P = .001–.01; ***P < .001).